Back to search

Article

Comprehensive genomic profiling of 30,000 consecutive solid tumors

2020-11-22

Abstract excerpt

<h4>Purpose</h4> Tissue-based comprehensive genomic profiling (CGP) is increasingly utilized for treatment selection in patients with advanced solid tumors, however real-world tissue availability may limit widespread implementation. Here we established real-world CGP tissue availability and assessed CGP performance on consecutively received samples. <h4>Patients and Method</h4> Post-hoc, non-prespecified analysis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
997890f9-0944-58e1-841e-af3e7fde6b75
DOI
10.1101/2020.11.19.20233866
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comprehensive genomic profiling of 30,000 consecutive solid tumorsDOI 10.1101/2020.11.19.20233866
Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fractionSemantic proximity
Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumorsSemantic proximity
A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancers.Semantic proximity
Comprehensive Genomic Profiling in Metastatic Solid Tumors: High Actionability But Low Implementation in Real-World PracticeSemantic proximity
Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.Semantic proximity
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer.Semantic proximity
Validation and Clinical Utility of a Pan-Cancer Circulating Tumor DNA Assay as a First-Approach Test.Semantic proximity
Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options: the PRECODE study protocolSemantic proximity
Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling – A report on the impact of process optimization through the analysis of 4,871 cytology samples profiled by MSK-IMPACTSemantic proximity
Clinical application of tumour whole genome sequencing in routine molecular diagnostics for solid cancer patientsSemantic proximity
The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicineSemantic proximity
Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testingSemantic proximity
Select a neighboring publication to make it the new centre.